Pharmacoeconomics: from theory to practice
"In this era of finite budgets, healthcare rationing, medication shortages, and the global aging and burgeoning of populations, numerous stakeholders in the healthcare arena must understand the basic principles of pharmacoeconomics and how these may be correctly applied to facilitate drug devel...
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Boca Raton
CRC Press
2021
|
| Ausgabe: | Second edition |
| Schlagworte: | |
| Zusammenfassung: | "In this era of finite budgets, healthcare rationing, medication shortages, and the global aging and burgeoning of populations, numerous stakeholders in the healthcare arena must understand the basic principles of pharmacoeconomics and how these may be correctly applied to facilitate drug development, rationing, patient segmentation, disease management, and pricing model development. Pharmacoeconomics: From Theory to Practice, Second Edition focuses on how to more efficiently and rationally leverage these healthcare resources, not by restricting access to necessary services, but by using them more efficiently. This updated volume arms decision makers with the tools they need to make wise choices in an area where the stakes are extremely high-the health of the global population"-- |
| Beschreibung: | xiv, 319 Seiten Illustrationen, Diagramme |
| ISBN: | 9781138589834 |
Internformat
MARC
| LEADER | 00000nam a22000008c 4500 | ||
|---|---|---|---|
| 001 | BV046944144 | ||
| 003 | DE-604 | ||
| 005 | 20210210 | ||
| 007 | t | ||
| 008 | 201016s2021 a||| b||| 00||| eng d | ||
| 020 | |a 9781138589834 |c hardback |9 978-1-138-58983-4 | ||
| 035 | |a (OCoLC)1220914790 | ||
| 035 | |a (DE-599)BVBBV046944144 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-703 |a DE-N2 |a DE-20 | ||
| 084 | |a QR 525 |0 (DE-625)142044: |2 rvk | ||
| 245 | 1 | 0 | |a Pharmacoeconomics |b from theory to practice |c edited by Renée J.G. Arnold, PharmD, RPh |
| 250 | |a Second edition | ||
| 264 | 1 | |a Boca Raton |b CRC Press |c 2021 | |
| 300 | |a xiv, 319 Seiten |b Illustrationen, Diagramme | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 520 | 3 | |a "In this era of finite budgets, healthcare rationing, medication shortages, and the global aging and burgeoning of populations, numerous stakeholders in the healthcare arena must understand the basic principles of pharmacoeconomics and how these may be correctly applied to facilitate drug development, rationing, patient segmentation, disease management, and pricing model development. Pharmacoeconomics: From Theory to Practice, Second Edition focuses on how to more efficiently and rationally leverage these healthcare resources, not by restricting access to necessary services, but by using them more efficiently. This updated volume arms decision makers with the tools they need to make wise choices in an area where the stakes are extremely high-the health of the global population"-- | |
| 650 | 0 | 7 | |a Kosten-Nutzen-Analyse |0 (DE-588)4032589-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
| 653 | 0 | |a Drugs / Cost effectiveness | |
| 653 | 0 | |a Pharmacy / Economic aspects | |
| 653 | 0 | |a Decision making | |
| 653 | 0 | |a Decision making | |
| 653 | 0 | |a Drugs / Cost effectiveness | |
| 653 | 0 | |a Pharmacy / Economic aspects | |
| 653 | 0 | |a ARZNEIMITTELENTWICKLUNG + ARZNEIMITTELDESIGN + ARZNEIMITTELENTDECKUNG / ger | |
| 653 | 0 | |a ARZNEIMITTELINDUSTRIE + ARZNEIMITTELHANDEL / ger | |
| 653 | 0 | |a ENTSCHEIDUNGSFINDUNG / ger | |
| 653 | 0 | |a GESUNDHEITSÖKONOMIE + GESUNDHEITSAUSGABEN / ger | |
| 653 | 0 | |a KOSTEN-NUTZEN-ANALYSE / ger | |
| 653 | 0 | |a MODELLRECHNUNG UND SIMULATION IN DER PHARMAZIE / ger | |
| 689 | 0 | 0 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
| 689 | 0 | 1 | |a Kosten-Nutzen-Analyse |0 (DE-588)4032589-1 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Arnold, Renée J. G. |0 (DE-588)139675620 |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |z 978-0-429-49136-8 |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-032352812 | ||
Datensatz im Suchindex
| _version_ | 1804181849999671296 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author2 | Arnold, Renée J. G. |
| author2_role | edt |
| author2_variant | r j g a rjg rjga |
| author_GND | (DE-588)139675620 |
| author_facet | Arnold, Renée J. G. |
| building | Verbundindex |
| bvnumber | BV046944144 |
| classification_rvk | QR 525 |
| ctrlnum | (OCoLC)1220914790 (DE-599)BVBBV046944144 |
| discipline | Wirtschaftswissenschaften |
| discipline_str_mv | Wirtschaftswissenschaften |
| edition | Second edition |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02643nam a22005058c 4500</leader><controlfield tag="001">BV046944144</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20210210 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">201016s2021 a||| b||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781138589834</subfield><subfield code="c">hardback</subfield><subfield code="9">978-1-138-58983-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1220914790</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046944144</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-703</subfield><subfield code="a">DE-N2</subfield><subfield code="a">DE-20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QR 525</subfield><subfield code="0">(DE-625)142044:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmacoeconomics</subfield><subfield code="b">from theory to practice</subfield><subfield code="c">edited by Renée J.G. Arnold, PharmD, RPh</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">Second edition</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boca Raton</subfield><subfield code="b">CRC Press</subfield><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xiv, 319 Seiten</subfield><subfield code="b">Illustrationen, Diagramme</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">"In this era of finite budgets, healthcare rationing, medication shortages, and the global aging and burgeoning of populations, numerous stakeholders in the healthcare arena must understand the basic principles of pharmacoeconomics and how these may be correctly applied to facilitate drug development, rationing, patient segmentation, disease management, and pricing model development. Pharmacoeconomics: From Theory to Practice, Second Edition focuses on how to more efficiently and rationally leverage these healthcare resources, not by restricting access to necessary services, but by using them more efficiently. This updated volume arms decision makers with the tools they need to make wise choices in an area where the stakes are extremely high-the health of the global population"--</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kosten-Nutzen-Analyse</subfield><subfield code="0">(DE-588)4032589-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Drugs / Cost effectiveness</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Pharmacy / Economic aspects</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Decision making</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Decision making</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Drugs / Cost effectiveness</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Pharmacy / Economic aspects</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">ARZNEIMITTELENTWICKLUNG + ARZNEIMITTELDESIGN + ARZNEIMITTELENTDECKUNG / ger</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">ARZNEIMITTELINDUSTRIE + ARZNEIMITTELHANDEL / ger</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">ENTSCHEIDUNGSFINDUNG / ger</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">GESUNDHEITSÖKONOMIE + GESUNDHEITSAUSGABEN / ger</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">KOSTEN-NUTZEN-ANALYSE / ger</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">MODELLRECHNUNG UND SIMULATION IN DER PHARMAZIE / ger</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Kosten-Nutzen-Analyse</subfield><subfield code="0">(DE-588)4032589-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Arnold, Renée J. G.</subfield><subfield code="0">(DE-588)139675620</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="z">978-0-429-49136-8</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-032352812</subfield></datafield></record></collection> |
| id | DE-604.BV046944144 |
| illustrated | Illustrated |
| index_date | 2024-07-03T15:38:50Z |
| indexdate | 2024-07-10T08:58:12Z |
| institution | BVB |
| isbn | 9781138589834 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-032352812 |
| oclc_num | 1220914790 |
| open_access_boolean | |
| owner | DE-703 DE-N2 DE-20 |
| owner_facet | DE-703 DE-N2 DE-20 |
| physical | xiv, 319 Seiten Illustrationen, Diagramme |
| publishDate | 2021 |
| publishDateSearch | 2021 |
| publishDateSort | 2021 |
| publisher | CRC Press |
| record_format | marc |
| spelling | Pharmacoeconomics from theory to practice edited by Renée J.G. Arnold, PharmD, RPh Second edition Boca Raton CRC Press 2021 xiv, 319 Seiten Illustrationen, Diagramme txt rdacontent n rdamedia nc rdacarrier "In this era of finite budgets, healthcare rationing, medication shortages, and the global aging and burgeoning of populations, numerous stakeholders in the healthcare arena must understand the basic principles of pharmacoeconomics and how these may be correctly applied to facilitate drug development, rationing, patient segmentation, disease management, and pricing model development. Pharmacoeconomics: From Theory to Practice, Second Edition focuses on how to more efficiently and rationally leverage these healthcare resources, not by restricting access to necessary services, but by using them more efficiently. This updated volume arms decision makers with the tools they need to make wise choices in an area where the stakes are extremely high-the health of the global population"-- Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd rswk-swf Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf Drugs / Cost effectiveness Pharmacy / Economic aspects Decision making ARZNEIMITTELENTWICKLUNG + ARZNEIMITTELDESIGN + ARZNEIMITTELENTDECKUNG / ger ARZNEIMITTELINDUSTRIE + ARZNEIMITTELHANDEL / ger ENTSCHEIDUNGSFINDUNG / ger GESUNDHEITSÖKONOMIE + GESUNDHEITSAUSGABEN / ger KOSTEN-NUTZEN-ANALYSE / ger MODELLRECHNUNG UND SIMULATION IN DER PHARMAZIE / ger Pharmakotherapie (DE-588)4076066-2 s Kosten-Nutzen-Analyse (DE-588)4032589-1 s DE-604 Arnold, Renée J. G. (DE-588)139675620 edt Erscheint auch als Online-Ausgabe 978-0-429-49136-8 |
| spellingShingle | Pharmacoeconomics from theory to practice Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd Pharmakotherapie (DE-588)4076066-2 gnd |
| subject_GND | (DE-588)4032589-1 (DE-588)4076066-2 |
| title | Pharmacoeconomics from theory to practice |
| title_auth | Pharmacoeconomics from theory to practice |
| title_exact_search | Pharmacoeconomics from theory to practice |
| title_exact_search_txtP | Pharmacoeconomics from theory to practice |
| title_full | Pharmacoeconomics from theory to practice edited by Renée J.G. Arnold, PharmD, RPh |
| title_fullStr | Pharmacoeconomics from theory to practice edited by Renée J.G. Arnold, PharmD, RPh |
| title_full_unstemmed | Pharmacoeconomics from theory to practice edited by Renée J.G. Arnold, PharmD, RPh |
| title_short | Pharmacoeconomics |
| title_sort | pharmacoeconomics from theory to practice |
| title_sub | from theory to practice |
| topic | Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd Pharmakotherapie (DE-588)4076066-2 gnd |
| topic_facet | Kosten-Nutzen-Analyse Pharmakotherapie |
| work_keys_str_mv | AT arnoldreneejg pharmacoeconomicsfromtheorytopractice |